February 2 is observed as Rheumatoid Arthritis Awareness Day to raise awareness about the condition, its causes, symptoms, treatment options, and more ...

February 2, 2025, marks Rheumatoid Arthritis Awareness Day—a day dedicated to shedding light on a debilitating disease that affects millions worldwide. While scientific literature extensively covers ...

World Rheumatoid Arthritis Day on February 2, 2025, is a powerful reminder of the importance of understanding rheumatoid ...

Five out of every 1,000 Malaysians are affected by Rheumatoid Arthritis (RA), a condition that causes chronic autoimmune ...

Medically reviewed by Stella Bard, MD Osteoarthritis (OA) and rheumatoid arthritis (RA) are two of the most common types of arthritis (joint inflammation). OA and RA have similarities, but they damage ...

Avtozma, the third biosimilar to Actemra, has received FDA approval for multiple inflammatory diseases and COVID-19, potentially expanding treatment access for patients.

The FDA approved Avtozma, a tocilizumab biosimilar developed by Celltrion, for the treatment of several rheumatic conditions.

Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.

The U.S. Food and Drug Administration (FDA) has approved Celltrion’s AVTOZMA (CT-P47, tocilizumab-anoh) in both an ...

Rheumatoid Arthritis Awareness Day 2025 falls on February 2 to raise awareness around the chronic autoimmune disease.

Current research has not found an association between rheumatoid arthritis and appendicitis, but some studies found a link between other autoimmune diseases and appendicitis.